ANDA OWNERSHIP TRANSFER AND PRODUCT LICENSE AGREEMENT This license agreement (the "Agreement") dated as of May 17, 2006 (the "Effective Date") is entered into by and between Nostrum Pharmaceuticals, Inc. ("Nostrum"), a Delaware corporation, and...Product License Agreement • May 19th, 2006 • Synovics Pharmaceuticals • Medicinal chemicals & botanical products • New York
Contract Type FiledMay 19th, 2006 Company Industry Jurisdiction
Equiduct Product Licence AgreementProduct License Agreement • September 29th, 2023
Contract Type FiledSeptember 29th, 2023Börse Berlin AG whose registered office is at Kurfürstendamm 129D, 10711 Berlin, Germany Licensee (Company name and Registered office)
Product Certificate Number XX-XX-XXXProduct License Agreement • November 6th, 2019
Contract Type FiledNovember 6th, 2019Agreed between and Framesoft AG Software Applications Customer Sumpfstrasse 15 CH-6302 Zug Switzerland - Hereinafter "Framesoft"- - Hereinafter " End User" -
PLEASE CAREFULLY READ THE FOLLOWING AGREEMENT. BY CLICKING ON THE “I ACCEPT” BUTTON AT THE END OF THIS AGREEMENT, YOU INDICATE YOUR ACCEPTANCE OF ITS TERMS AND CONDITIONS AND AGREE TO BE BOUND AS SET FORTH HEREIN. YOU REPRESENT AND WARRANT THAT YOU...Product License Agreement • May 5th, 2020 • Tennessee
Contract Type FiledMay 5th, 2020 JurisdictionThis Product License Agreement (the “Agreement”) by and between UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, a non-profit corporation organized and existing under the laws of the State of Tennessee, and having a place of business at 600 Henley Street, UT Conference Center Suite 211, Knoxville, Tennessee 37996 (“UTRF”), and you and your institution (“Licensee”) constitutes a legally binding agreement and governs Licensee’s use of the Product (as defined below).
PRODUCT LICENSE AGREEMENT BY AND BETWEEN EMERGENT BIOSOLUTIONS INC. AND APTEVO THERAPEUTICS INC. DATED AS OF [•], 2016Product License Agreement • June 29th, 2016 • Aptevo Therapeutics Inc. • Pharmaceutical preparations
Contract Type FiledJune 29th, 2016 Company IndustryThis PRODUCT LICENSE AGREEMENT (this “Agreement”), effective as of [ ] (the “Effective Date”), is by and between Emergent BioSolutions, Inc., a corporation organized under the laws of Delaware and having its corporate head office located at 400 Professional Drive, Suite 400, Gaithersburg, MD 20879 (“Emergent”), and Aptevo Therapeutics, Inc., a corporation organized under the laws of Delaware and having its principal place of business at 2401 4th Ave. Suite 1050, Seattle, WA 98121 (“Aptevo”). Unless otherwise defined in this Agreement, all capitalized terms used in this Agreement shall have the meaning set forth in the Separation and Distribution Agreement (“SDA”) or, if not therein, in the Transition Services Agreement (“TSA”), or, if not therein, in the Manufacturing Services Agreement (“MSA”), or, if not therein, in the Canadian Distributor Agreement (“CDA”), each dated as of the date hereof, by and between Emergent and Aptevo, each as may be amended.
COVERITY PRODUCT LICENSE AGREEMENTProduct License Agreement • September 15th, 2020 • California
Contract Type FiledSeptember 15th, 2020 JurisdictionUNLESS YOU HAVE OBTAINED PERMISSION TO USE THE SOFTWARE UNDER A SEPARATE, DULY SIGNED LICENSE AGREEMENT OR AN EVALUATION LICENSE WITH COVERITY OR AN AUTHORIZED DISTRIBUTOR, THE ACCOMPANYING SOFTWARE IS PROVIDED UNDER THE FOLLOWING TERMS AND CONDITIONS AND ANY SUPPLEMENTAL TERMS REFERENCED BELOW AND YOUR RIGHT TO USE THE SOFTWARE IS CONDITIONED UPON YOUR ACCEPTANCE OF THIS AGREEMENT.
Equiduct Product Licence AgreementProduct License Agreement • October 12th, 2022
Contract Type FiledOctober 12th, 2022VBBO is a real-time data feed providing, for any security traded in Equiduct’s Apex and Zenith trading services, the Volume Weighted Best Bid and Offer for: Retail Market Size (RMS) (~7,500€), Standard Market Size (SMS, where defined by ESMA), Max Apex Size (PEX) and Max Zenith Size (SVB). The VBBO is calculated on the basis of a virtual order book formed from consolidated visible order book depth from relevant markets. The VBBO data product provides pre-trade transparency for the Apex and Zenith services.
PRODUCT LICENSE AGREEMENTProduct License Agreement • December 10th, 2013 • Ixys Corp /De/ • Semiconductors & related devices
Contract Type FiledDecember 10th, 2013 Company IndustryThis Product License Agreement (“Agreement”) is entered into on the 27th day of June, 2013 (the “Effective Date”) by and between Samsung Electronics Co., Ltd., a company duly incorporated under the laws of the Republic of Korea, acting through its System LSI Division, with principal offices located at San #24, Nongseo-Dong, Giheung-Gu, Yongin-City, Gyeonggi-Do, 449-711 Korea (“Samsung”), and IXYS Intl Limited, a corporation organized under the laws of the Cayman Islands, with a principal place of business at 190 Elgin Avenue, George Town, Grand Cayman, KY1-9005 Cayman Islands (“IXYS”).
Product License AgreementProduct License Agreement • September 11th, 2021
Contract Type FiledSeptember 11th, 2021The Government of Canada (Statistics Canada) is the owner or a licensee of all intellectual property rights (including copyright) in this data product. In consideration of your payment of the requisite fee, you (hereinafter referred to as the "licensee") are granted a non-exclusive, non-assignable and non-transferable licence to use this data product subject to the terms below.
MUSIC4CLIMATEJUSTICE PRODUCT LICENSE AGREEMENTProduct License Agreement • September 22nd, 2021 • New Jersey
Contract Type FiledSeptember 22nd, 2021 JurisdictionThis is an agreement between you (“Licensee”) and MUSIC4CLIMATEJUSTICE (“Music4ClimateJustice” or “M4CJ” or “Licensor”). By clicking next to “I ACCEPT THE TERMS” IN THE END USER LICENSE
Portions of this Exhibit have been redacted because they are both (i) not material and (ii) the registrant customarily and actually treats such information as private or confidential. Information that was omitted has been noted in this document with a...Product License Agreement • July 2nd, 2021 • Rallybio Corp • Pharmaceutical preparations
Contract Type FiledJuly 2nd, 2021 Company IndustryTHIS AMENDMENT NO 2 to the Product License Agreement dated March 9, 2012, as subsequently supplemented by a Letter Agreement dated November 4, 2015 and amended by Amendment No. 1 dated January 1, 2018 (the “C5 PLA”), is entered into with effect as of 22 December 2020, and made between:
PRODUCT LICENSE AGREEMENT TERMS AND CONDITIONSProduct License Agreement • March 10th, 2020 • Massachusetts
Contract Type FiledMarch 10th, 2020 JurisdictionAs a condition of using Forum Systems, Inc.’s (“Forum Systems’”) products that are purchased or used by Licensee including the hardware (the “Hardware”) and the software, including the device drivers, the configuration management tools and the standard issued versions of the software (collectively referred to as the “Software”) and any related recorded media, documentation and all future orders (all items in this paragraph are collectively referred to as the “Products”), Licensee agrees to all of the terms and conditions of this Product License
END USER LICENSE AGREEMENTProduct License Agreement • June 8th, 2016 • California
Contract Type FiledJune 8th, 2016 JurisdictionThis is a legal agreement (“Agreement”) between you, the end user, and piXlogic, Inc. (“MANUFACTURER”), a California corporation with its principal place of business at 4984 El Camino Real., Los Altos, CA 94022, U.S.A., which covers the piXserve (pXs) software developed by MANUFACTURER and distributed by Flex Analytics LLC, a Maryland company (“VALUE ADDED RESELLER”) with its principal place of business at 10314 Thornbush Lane, Bethesda MD 20814, U.S.A. (the “Software”) and its accompanying documentation (“Documentation”). The term “you” in this Agreement refers to the individual or organization that initially purchased the Software, in such quantities and at such prices as identified in your purchase order to VALUE ADDED RESELLER (the “Schedule”)
CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED FIRST AMENDMENT TO PRODUCT LICENSE AGREEMENTProduct License Agreement • February 16th, 2021 • PLBY Group, Inc. • Retail-miscellaneous retail
Contract Type FiledFebruary 16th, 2021 Company IndustryTHIS FIRST AMENDMENT TO PRODUCT LICENSE AGREEMENT (this “Amendment”), effective as of the latest dated signature of the parties below (the “Amendment Effective Date”), by and between CHINA PRODUCTS LICENSING LLC (by virtue of assignment by Playboy Enterprises International, Inc.) and NEW HANDONG INVESTMENT (GUANGDONG) CO., LTD. hereby amends that certain Product License Agreement entered into by and between Licensor and Licensee effective as of December 6, 2019 (the “Agreement”). This Amendment is hereby incorporated into the Agreement by reference. All capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the Agreement.
ContractProduct License Agreement • August 10th, 2017
Contract Type FiledAugust 10th, 2017Please note that by using the ‘Rosie 2’ organisational package (the “Product”) you (the “User”) agree to abide by the Terms and Conditions and the additional specific conditions relating to the licence of the Product as set out below. Together these constitute the Agreement which was agreed when purchasing the Product.
GLOBAL VELOCITY PRODUCT LICENSE AGREEMENT / EULA AND WARRANTY TERMSProduct License Agreement • September 12th, 2020 • Missouri
Contract Type FiledSeptember 12th, 2020 JurisdictionTHESE TERMS APPLY TO THE USE OF GLOBAL VELOCITY, INC. (“GLOBAL VELOCITY”) PRODUCT BY ANY PERSON OR ENTITY PURCHASING (OR LICENSING) SUCH PRODUCT FROM GLOBAL VELOCITY OR ITS AUTHORIZED RESELLERS OR DISTRIBUTORS (“CUSTOMER”).
PRODUCT LICENSE AGREEMENT This Agreement is made as of the date of execution hereof between the corporation described in the First Schedule of Appendix "A" attached hereto and made a part hereof (hereinafter called the "Licensor") and the company...Product License Agreement • April 2nd, 2001 • Pure Steel Custom Cycles Inc • New York
Contract Type FiledApril 2nd, 2001 Company Jurisdiction
IMPORTANT! THIS IS A CONTRACT BETWEEN CENTAUR SOFTWARE DEVELOPMENT PTY LTD (ACN 18 057 620 390) (CENTAUR) AND YOU. BY USING CENTAURS APPLICATIONS (PRODUCTS/SERVICES), THE CONTENTS AND FEATURES, RELATED USER GUIDES AND MATERIALS, INCLUDING ALL...Product License Agreement • April 19th, 2024 • New South Wales
Contract Type FiledApril 19th, 2024 JurisdictionThis PLA covers the below Products/Services (“Services”) through a combination of General Service Clauses (that apply to all Services) and Service Clauses (that apply to specific Services only).
PRODUCT LICENSE AGREEMENTProduct License Agreement • October 21st, 2015 • California
Contract Type FiledOctober 21st, 2015 JurisdictionThis Product License Agreement (“Agreement”) is entered into by and between UNICOM Systems, Inc. ("Licensor"), and Licensee ("Licensee") (Licensor and Licensee are collectively, the “Parties”); and establishes the general terms and conditions by which Licensee shall acquire a License (defined below) to use Licensor's software products, programs, documentation, education and professional services, (hereinafter collectively referred to as “Product”).
Equiduct Product Licence AgreementProduct License Agreement • October 29th, 2020
Contract Type FiledOctober 29th, 2020VBBO is a real-time data feed providing, for any security traded in Equiduct’s Apex and SpotVBBO trading services, the Volume Weighted Best Bid and Offer for Retail Market Size (RMS) (~7,500€), Standard Market Size (SMS, where defined by ESMA), Max Apex Size (PEX) and Max SpotVBBO Size (SVB). The VBBO is calculated on the basis of a virtual order book formed from consolidated visible level 2 data from relevant markets. The VBBO data product provides pre-trade transparency for the Apex and SpotVBBO services.
HEALRWORLD, LLC PRODUCT LICENSE AGREEMENTProduct License Agreement • June 5th, 2019 • New Jersey
Contract Type FiledJune 5th, 2019 Jurisdictionliability company (“HealRWorld” or “Licensor”). By clicking next to “I ACCEPT THE TERMS” IN THE END USER LICENSE AGREEMENT”, you are agreeing to the terms of this Product License Agreement (the “Agreement”). IF YOU ARE NOT WILLING TO BE BOUND BY THE AGREEMENT, DO NOT ACCEPT THE TERMS IN THE DATA & PRODUCT END USER LICENSE AGREEMENT” and terminate the
IMPORTANT NOTICE:Product License Agreement • November 18th, 2019
Contract Type FiledNovember 18th, 2019You must read this Product License Agreement (“Agreement”) carefully before completing your order for the Product. This Agreement sets out the terms and conditions on which Clifftop Software LLC licenses the Product to the Licensee. You represent and warrant that you have authority to enter into this Agreement with Clifftop Software LLC on behalf of the Licensee, that you have read the terms and conditions set out herein and that the Licensee agrees to be bound by the terms and conditions.
Product Certificate Number XX-XX-XXXProduct License Agreement • November 1st, 2019
Contract Type FiledNovember 1st, 2019Agreed between and Framesoft AG Software Applications Customer Sumpfstrasse 15 CH-6302 Zug Switzerland - Hereinafter "Framesoft"- - Hereinafter " End User" -
AIR TRANSPORT ASSOCIATION OF AMERICA, INC. ("ATA") PRODUCT LICENSE AGREEMENTProduct License Agreement • March 18th, 2011 • District of Columbia
Contract Type FiledMarch 18th, 2011 JurisdictionBY PRESSING THE "I ACCEPT" BUTTON BELOW, YOU AGREE TO BE BOUND BY THE TERMS OF, AND BECOME PARTY TO, THIS AGREEMENT. THIS AGREEMENT IS APPLICABLE TO THE ACCOMPANYING MERCHANDISE (THE "MERCHANDISE"), THE INFORMATION RESIDING THEREON OR ON INTERNET WEB SITES ACCESSIBLE EXCLUSIVELY VIA LINKS FROM THE MERCHANDISE (THE "CONTENT") AND THE RELATED SOFTWARE (COLLECTIVELY, THE "LICENSED PRODUCT"). IF YOU DO NOT AGREE TO BE BOUND BY THE TERMS OF, AND BECOME PARTY TO, THIS AGREEMENT, PRESS THE "I DO NOT ACCEPT" BELOW. IF YOU PRESS THE "I DO NOT ACCEPT" BUTTON, YOU WILL NOT BE ABLE TO INSTALL THE LICENSED PRODUCT OR ACCESS THE INFORMATION IT CONTAINS.
SECOND AMENDED AND RESTATED NOVAVAX PRODUCT LICENSE AGREEMENTProduct License Agreement • November 7th, 2018 • Novavax Inc • Biological products, (no disgnostic substances)
Contract Type FiledNovember 7th, 2018 Company IndustryThis SECOND AMENDED AND RESTATED NOVAVAX PRODUCT LICENSE AGREEMENT (the “Agreement”) is effective as of the 17th day of July, 2018 (the “Effective Date”), by and between
Portions of this Exhibit have been redacted because they are both (i) not material and (ii) the registrant customarily and actually treats such information as private or confidential. Information that was omitted has been noted in this document with a...Product License Agreement • July 2nd, 2021 • Rallybio Corp • Pharmaceutical preparations
Contract Type FiledJuly 2nd, 2021 Company IndustryThis Agreement (the “Agreement”), is made and entered into as of 9 March 2012 (the “Effective Date”) by and between Affibody AB, company registration no. 556665-6913, Gunnar Asplunds Allé 24, SE-171 63 Solna (“Licensor”), and Swedish Orphan Biovitrum AB (publ), (previously Biovitrum AB publ) |company registration no. 556038-9321, Tomtebodavagen 23 A, SE-112 76 Stockholm, Sweden (“Licensee”); individually a “Party”, together the “Parties”.
This PRODUCT LICENNSE AGREEMENT (the “Agreement”)Product License Agreement • December 20th, 2018 • Florida
Contract Type FiledDecember 20th, 2018 JurisdictionIN CONSIDERATION OF the provisions contained in this agreement and for other good and valuable consideration, the receipt and sufficiency of which is acknowledged, the parties agree as follows:
ContractProduct License Agreement • November 26th, 2023
Contract Type FiledNovember 26th, 2023
PRODUCT LICENSE AGREEMENT BY AND BETWEEN EMERGENT BIOSOLUTIONS INC. AND APTEVO THERAPEUTICS INC. DATED AS OF JULY 29, 2016Product License Agreement • August 2nd, 2016 • Aptevo Therapeutics Inc. • Pharmaceutical preparations
Contract Type FiledAugust 2nd, 2016 Company IndustryThis PRODUCT LICENSE AGREEMENT (this “Agreement”), effective as of July 29, 2016 (the “Effective Date”), is by and between Emergent BioSolutions, Inc., a corporation organized under the laws of Delaware and having its corporate head office located at 400 Professional Drive, Suite 400, Gaithersburg, MD 20879 (“Emergent”), and Aptevo Therapeutics, Inc., a corporation organized under the laws of Delaware and having its principal place of business at 2401 4th Ave. Suite 1050, Seattle, WA 98121 (“Aptevo”). Unless otherwise defined in this Agreement, all capitalized terms used in this Agreement shall have the meaning set forth in the Separation and Distribution Agreement (“SDA”) or, if not therein, in the Transition Services Agreement (“TSA”), or, if not therein, in the Manufacturing Services Agreement (“MSA”), or, if not therein, in the Canadian Distributor Agreement (“CDA”), each dated as of the date hereof, by and between Emergent and Aptevo, each as may be amended.
《Scope of Warranty》Product License Agreement • September 28th, 2015
Contract Type FiledSeptember 28th, 2015This product license agreement (hereinafter referred to as this “Agreement”) is a legal agreement between the product user outside Japan (an individual person or a corporation, hereinafter referred to as “You”) and ORIGINALMIND. CO. JP (hereinafter referred to as “Our Company”) executed for the KitMill series products and other original products (hereinafter referred to as the “Product”). Upon the purchase of the Product, if You have had means or opportunity to read this Agreement before the purchase of this Product, or upon unpacking the Product, if You had had no such opportunity before the purchase, You are deemed to have accepted to be bound by the provisions of this Agreement. Thereafter, Your demand for Your returning of the Product or refundment therefor shall not be accepted.
Hondata Installation ManualProduct License Agreement • August 3rd, 2001
Contract Type FiledAugust 3rd, 2001While Hondata believes that our product is safe and useful, and that every effort has been made to ensure the quality of the product, Hondata is not responsible for any damage that may arise from the use of this product. No guarantee is made about the performance of this product. By using this product (including software and any hardware) you agree to abide by these terms.
ECAVA SVG Image Library PRODUCT LICENSE AGREEMENTProduct License Agreement • February 8th, 2021
Contract Type FiledFebruary 8th, 2021NOTICE TO USERS: CAREFULLY READ THE FOLLOWING LEGAL AGREEMENT. USE OF THE LIBRARY PROVIDED WITH THIS AGREEMENT (THE "LIBRARY") CONSTITUTES YOUR ACCEPTANCE OF THESE TERMS. IF YOU DO NOT AGREE TO THE TERMS OF THIS AGREEMENT, DO NOT INSTALL AND/OR USE THIS LIBRARY. USER'S USE OF THIS LIBRARY IS CONDITIONED UPON COMPLIANCE BY USER WITH THE TERMS OF THIS AGREEMENT.
PLEASE CAREFULLY READ THE FOLLOWING TERMS AND CONDITIONS. THESE TERMS AND CONDITIONS ARE AUTOMATICALLY ACCEPTED BY PURCHASING THE BODY LIFE DIRECT SYSTEM SOFTWARE. BY LICENSING BODY LIFE DIRECT SYSTEM PRODUCTS (BLD) YOU WARRANT THAT YOU ARE EIGHTEEN...Product License Agreement • September 5th, 2010
Contract Type FiledSeptember 5th, 2010of the BODY LIFE DIRECT SYSTEM SOFTWARE (“Products”). Company may, in its sole discretion and at any time,modify or change these terms and conditions governing the license of its Products.
Equiduct Product Licence AgreementProduct License Agreement • March 30th, 2021
Contract Type FiledMarch 30th, 2021VBBO is a real-time data feed providing, for any security traded in Equiduct’s Apex and SpotVBBO trading services, the Volume Weighted Best Bid and Offer for Retail Market Size (RMS) (~7,500€), Standard Market Size (SMS, where defined by ESMA), Max Apex Size (PEX) and Max SpotVBBO Size (SVB). The VBBO is calculated on the basis of a virtual order book formed from consolidated visible level 2 data from relevant markets. The VBBO data product provides pre-trade transparency for the Apex and SpotVBBO services.
Equiduct Product Licence AgreementProduct License Agreement • September 30th, 2021
Contract Type FiledSeptember 30th, 2021VBBO is a real-time data feed providing, for any security traded in Equiduct’s Apex and Zenith trading services, the Volume Weighted Best Bid and Offer for: Retail Market Size (RMS) (~7,500€), Standard Market Size (SMS, where defined by ESMA), Max Apex Size (PEX) and Max Zenith Size (SVB). The VBBO is calculated on the basis of a virtual order book formed from consolidated visible order book depth from relevant markets. The VBBO data product provides pre-trade transparency for the Apex and Zenith services.